title: A Cost-Effectiveness Analysis Of Onabotulinumtoxina Verse. Best Supportive Care (bsc) For The Treatment Of Anticholinergic Treatment-Refractory Neurogenic Detrusor Overactivity (ndo).
authors.affiliation: Department of NeuroUrology, Royal National Orthopaedic Hospital & University College Hospital, London, UK, Stanmore, UK.
authors.forename: R
authors.initials: R
authors.lastname: Hamid
authors.affiliation: Allergan Holdings Ltd., Marlow, UK.
authors.forename: C
authors.initials: C
authors.lastname: Loveman
authors.affiliation: Allergan Holdings Ltd., Marlow, UK.
authors.forename: J
authors.initials: J
authors.lastname: Millen
authors.affiliation: Allergan, Inc., Irvine, CA, USA.
authors.forename: D
authors.initials: D
authors.lastname: Colayco
authors.affiliation: The LASER Group, Milano, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Stanisic
authors.affiliation: The LASER Group, Loerrach, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Gultyaev